CDEK
← All organizations

Glaukos Corporation

For profitWebsite ↗

Also known as: GLAUKOS | GLAUKOS CORP | Glaukos Corporation

Phase 1Phase 2Phase 3Phase 4

Highest phase reached

Phase 4

First clinical trial

May 1, 2009

First marketed drug

Feb 7, 2012

Last known activity

Jan 5, 2026

Timeline

1990s

  1. Jun 1, 1998

    Glaukos Corporation— Founded

2010s

  1. Apr 15, 2016

    riboflavin— Marketing Organization

  2. Apr 15, 2016

    riboflavin— NDA Secondary Org

  3. Jun 27, 2019

    Dose Medical Corp— Acquired

  4. Aug 7, 2019

    Avedro, Inc.Avedro, Inc.— Acquired

Drugs by trial phase (8 distinct, 26 trials)

Phase 3 (0 own, 1 via acquisition)

Phase 2 (1 own, 0 via acquisition)

Indications

Studied for

Marketed drugs (3)

Subsidiaries (2 direct, 2 total across the full acquisition tree)

Recent trials (27)

Details

Founded
San Clemente, CA, US Jun 1, 1998
Last known activity
Jan 5, 2026